The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,401.00
Bid: 3,400.00
Ask: 3,401.00
Change: 18.00 (0.53%)
Spread: 1.00 (0.029%)
Open: 3,389.00
High: 3,403.00
Low: 3,372.00
Prev. Close: 3,383.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian Q3 FY24 trading update

16 Jan 2024 07:00

RNS Number : 7525Z
Experian plc
16 January 2024
 

news release

 

 

Trading update, third quarter

 

 

16 January 2024 ? Experian plc, the global information services company, today issues an update on trading for the three months ended 31 December 2023.

 

Brian Cassin, Chief Executive Officer, commented:

 

"We delivered good growth in Q3, at the upper end of our expectations. Revenue was up 9% at actual exchange rates from ongoing activities and 7% at constant exchange rates, with organic revenue growth of 6%.

 

For FY24, we now expect full year organic revenue growth to be between 5-6%, with modest margin accretion, all at constant exchange rates and on an ongoing basis."

 

% change in revenue from ongoing activities year-on-year for the three months ended 31 December 2023

Ongoing activities only

Total revenue growth %

Total revenue growth %

Organic revenue growth %

 

At actual

exchange rates1

At constant exchange rates

At constant exchange rates

North America

6

6

5

Latin America

25

17

13

UK and Ireland

9

3

3

EMEA and Asia Pacific

8

8

7

Total global

9

7

6

1 Experian reports in US dollars.

 

% change in organic revenue year-on-year for the three months ended 31 December 2023

Organic revenue growth %2

Data

Decisioning

B2B3

Consumer Services

Total

 

 

North America

3

4

3

9

5

Latin America

9

12

10

26

13

UK and Ireland

9

(6)

3

0

3

EMEA and Asia Pacific

3

17

7

n/a

7

Total global

5

5

5

10

6

2 Ongoing activities only, at constant exchange rates.

3 B2B = Business-to-Business segment which consists of Data and Decisioning business sub-divisions.

 

Business mix including % change in organic revenue year-on-year for the three months ended 31 December 2023

Segment

 

Business unit

% of Group revenue4

Q3 organic revenue growth %5

North America

67%

5%

 Data

CI / BI Bureaux

23%

2%

- CI / BI Bureaux, excluding mortgage

21%

3%

- Mortgage

2%

(6)%

Automotive

5%

10%

Targeting

4%

3%

 Decisioning

Health

8%

7%

DA / Other

5%

(1)%

 Consumer Services

Consumer Services

22%

9%

Latin America

15%

13%

 Data

CI / BI Bureaux

9%

10%

Other

0%

(11)%

 Decisioning

DA / Other

3%

12%

 Consumer Services

Consumer Services

3%

26%

UK and Ireland

12%

3%

 Data

CI / BI Bureaux

5%

9%

Targeting / Auto

1%

11%

 Decisioning

DA / Other

3%

(6)%

 Consumer Services

Consumer Services

3%

0%

EMEA and Asia Pacific

6%

7%

Total global

100%

6%

4 Percentage of Group revenue from ongoing activities calculated based on FY24 H1 revenue at actual exchange rates.

5 Ongoing activities only, at constant exchange rates.

CI = Consumer Information, BI = Business Information, DA = Decision Analytics.

 

North America - 67% of Group revenue4

 

North America delivered organic revenue growth of 5%. Total revenue growth was 6% including the contribution from an acquisition in health completed during the quarter.

 

B2B organic revenue growth was 3%.

 

Positive contributions from Clarity, Experian Ascend and Employer Services plus growth across larger clients offset continued volume weakness in smaller fintechs and mortgage. Automotive delivered strongly led by higher marketing activity by clients seeking to stimulate sales of new and used vehicle inventory. Health performed strongly with positive contributions from major product lines and from new products.

 

Consumer Services delivered organic revenue growth of 9%. We added to our member count to take our free membership base to 69m. Premium services performed well as did the insurance marketplace where new carrier on-boarding has boosted policy volumes. The credit marketplace continues to reflect constraints in credit supply. Partner Solutions performed very well, benefiting from one-time business wins for databreach services.

Latin America - 15% of Group revenue4

Latin America delivered organic revenue growth of 13%. At constant currency, total revenue growth was 17%, including contributions from acquisitions.

 

B2B organic revenue growth was 10%. In Brazil, we continue to grow our relationships with clients and build out new vertical opportunities. Growth was driven by adoption of positive data scores and analytics, our cloud-based decisioning tools and fraud and identity management capabilities. Our agribusiness vertical also performed strongly. Spanish Latin America benefited from expansion in scores, analytics and fraud and identity management.

 

Consumer Services delivered organic revenue growth of 26%. We have added to our free membership base, which reached the milestone of 100m in total for the region (Brazil 86m and Spanish Latin America 14m). In Brazil, we benefited from positive contributions from our Limpa Nome debt resolution service and expanded e-wallet payment integrations.

 

UK and Ireland - 12% of Group revenue4

 

The UK and Ireland delivered organic revenue of growth of 3%. Total constant currency growth at constant exchange rates was also 3%.

 

B2B organic revenue growth was 3%. We continue to perform strongly across consumer bureau activities, outperforming the credit issuance market where trends remain weak. This has been driven by sizeable new business wins and new product initiatives, with strong performances for Ascend, analytics and affordability products. Other Data activities also performed well. Decisioning performance reflected deal phasing and the transition from legacy on-premise software products to cloud-based solutions.

 

Organic revenue in Consumer Services was flat. This reflects continued stability in subscription revenue trends and a positive contribution from databreach services. Marketplace revenues continue to reflect soft market conditions. Free memberships were 13m.

 

EMEA and Asia Pacific - 6% of Group revenue4

 

In EMEA and Asia Pacific, organic revenue growth was 7%. Total constant currency revenue growth was 8%. There was strong progress across a number of key markets, including Australia, India and Italy.

 

Future events

 

Experian will release results for the full year ending 31 March 2024 on Wednesday, 15 May 2024.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Nick Jones Media queries

 

Teneo

Graeme Wilson, Louise Male and Jessica Reid +44 (0)20 7353 4200

 

This announcement is available on the Experian website at www.experianplc.com. There will be a conference call today to discuss this update at 9.00am (UK time), which will be broadcast live on the website with a recording available later.

 

All financial information in this trading update is based on unaudited management accounts. Certain statements made in this trading update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 22,400 people operating across 32 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. With corporate headquarters in Dublin, Ireland, we are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFUFWIELSEEF
Date   Source Headline
13th Sep 20195:01 pmRNSTransaction in Own Shares
12th Sep 20195:20 pmRNSTransaction in Own Shares
11th Sep 20195:09 pmRNSTransaction in Own Shares
10th Sep 20195:10 pmRNSTransaction in Own Shares
30th Aug 201911:58 amRNSTotal Voting Rights
22nd Aug 20199:37 amRNSAdditional Listing
21st Aug 20198:00 amRNSExperian acquires Look Who's Charging
15th Aug 20195:09 pmRNSTransaction in Own Shares
8th Aug 201911:00 amRNSAcquisition of MyHealthDirect
6th Aug 20195:05 pmRNSTransaction in Own Shares
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan
30th Apr 20193:26 pmRNSTotal Voting Rights
10th Apr 20191:17 pmRNSAdditional Listing
4th Apr 20192:38 pmRNSIrrevocable and non-discretionary arrangement
29th Mar 20192:36 pmRNSTotal Voting Rights
25th Mar 20195:08 pmRNSTransaction in Own Shares
19th Mar 20194:22 pmRNSBlock listing Interim Review
14th Mar 20195:22 pmRNSTransaction in Own Shares
12th Mar 20195:33 pmRNSTransaction in Own Shares
28th Feb 20192:38 pmRNSTotal Voting Rights
27th Feb 20197:49 amRNSAmended: Update on proposed ClearScore acquisition
27th Feb 20197:00 amRNSUpdate on proposed ClearScore acquisition
20th Feb 201911:19 amRNSAdditional Listing
25th Jan 201911:00 amRNSIssue of Notes
23rd Jan 20199:15 amRNSAdditional Listing
17th Jan 20197:00 amRNSTrading update, third quarter
11th Jan 20195:52 pmRNSFirst interim dividend
3rd Jan 20194:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.